Surmodics | 销售和管理费用

金融业

USD

USD 178.56M

现金及等价物

USD 36.12M

USD 33.03M

USD 81.3M

USD 20.54M

USD 29.55M

股息收益率

0

USD -322K

USD 1.53M

376

EPS每股收益

USD -0.25

股本和储备

USD 118.9M

USD -11.54M

债务利息支出

USD 884K

USD 29.55M

USD 393.5M

USD -11.54M

USD -245.35M

USD -5.65M

普通股股本

USD 716K

386.18

USD -7.51M

USD 29.92M

销售和管理费用

USD 14.58M

USD 15.17M

贸易债权人

USD 2.79M

应收帐款人

USD 23.27M

	销售和管理费用	更改		日
Abbott	USD 3.13B		125M	2025-12
Align Technology	USD 441.68M		23.88M	2025-12
Anika Therapeutics	USD 12.91M		17.8M	2025-03
Arrowhead Research	USD 46.02M		8.84M	2025-12
Baxter International	USD 708M		10M	2025-09
Boston Scientific	USD 1.83B		93M	2025-12
EDAP TMS	EUR 10.38M		1.15M	2025-06
Edwards Lifesciences	USD 602.9M		88.3M	2025-12
Haemonetics	USD 109.15M		7.54M	2025-12
Heron Therapeutics	USD 23.34M		4.18M	2024-09
J&J	USD 6.75B		831M	2025-12
Merit Medical Systems	USD 107.38M		5.72M	2025-09
Mesa Laboratories	USD 27.31M		380K	2024-09
Nektar Therapeutics	USD -0.18		0.07	2024-09
Option Care Health	USD 172.1M		2.01M	2025-09
Stryker	USD 2.14B		150M	2025-12
Surmodics	USD 14.58M		2.05M	2024-09
Trinity Biotech	USD 6.19M		2.18M	2025-09

Surmodics 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.